IL-18 has been reported to synergistically induce IFN-γ production by CD8+ T and NK cells with IL-12, followed by a direct tumor-killing function through the Fas-FasL and TRAIL mechanisms [28,29]. The gene discussed is CD8A; the disease is neoplasm.